Shadi Tabibian: Normal Tests, Abnormal Bleeding
Shadi Tabibian, Deputy of research at Blood Diseases Research Centers in Iran University of Medical Sciences, shared a post on LinkedIn:
“Bleeding Disorders of Unknown Cause (BDUC) represent one of the most challenging areas in contemporary haemostasis.
Although patients experience clinically significant bleeding manifestation, including heavy menstrual bleeding, mucocutaneous bleeding, easy bruising, and procedure-related haemorrhage, standard haemostatic investigations frequently fail to identify an underlying defect.
As a result, many individuals, particularly women, face prolonged diagnostic delay, repeated specialist consultations, fragmented care pathways, and substantial psychosocial burden.
Emerging evidence suggests that BDUC is not a benign condition.
Patients report impaired quality of life, iron deficiency, reduced physical functioning, anxiety, and significant impacts on education, employment, and social participation. Importantly, the absence of a laboratory diagnosis does not equate to the absence of disease.
This infographic summarizes the multidimensional burden of BDUC in women, highlighting the interconnected relationship between bleeding symptoms, diagnostic uncertainty, healthcare challenges, physical consequences, and psychological impact.
Greater awareness, standardized diagnostic pathways, comprehensive phenotyping, and continued research into currently unexplained bleeding phenotypes are essential to improve outcomes for this underserved patient population.”

Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian